Targeted protein degradation: expanding the toolbox
By M. Schapira, M. Calabrese, A. Bullock, C. Crews. Nature reviews. Drug discovery, 2019
767 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/e0debf22cb71e620d39f15414542d197d4f114e8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Structural insights into Cullin4-RING ubiquitin ligase remodelling by Vpr from simian immunodeficiency viruses (2021, background): “in the form of proteolysis-targeting chimera-(PROTAC-) or molecular glue-type compounds [83,84].”
- Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs (2022, methodology): “” PROteolysis TArgeting Chimeras (PROTACs) are a promising therapeutic modality that utilizes the Ubiquitin-Proteasome System (UPS) to selectively induce target protein degradation (TPD) (1).”